|
91
|
300
|
7balA |
Crystal structure of sars-cov-2 main protease treated with ebselen derivative of mr6-31-2 |
|
87
|
304
|
7bakA |
Crystal structure of sars-cov-2 main protease treated with ebselen |
|
182
|
635
|
7mswA |
Full length sars-cov-2 nsp2 |
|
157
|
502
|
7msxA |
Sars-cov-2 nsp2 |
|
87
|
306
|
7mrrA |
Crystal structure of sars-cov-2 main protease (3clpro/mpro) in complex with covalent inhibitor leupeptin |
|
29
|
131
|
7diyA |
Crystal structure of sars-cov-2 nsp10 bound to nsp14-exoribonuclease domain |
|
66
|
286
|
7diyB |
Crystal structure of sars-cov-2 nsp10 bound to nsp14-exoribonuclease domain |
|
71
|
306
|
7mhnA |
Ensemble refinement structure of apo/unliganded sars-cov-2 main protease (mpro) at 277 k |
|
71
|
306
|
7mhqA |
Ensemble refinement structure of apo/unliganded sars-cov-2 main protease (mpro) at 310 k |
|
85
|
303
|
7mpbA |
Sars coronavirus-2 main protease 3cl-pro binding ascorbate |
|
84
|
306
|
7mhkA |
Crystal structure of apo/unliganded sars-cov-2 main protease (mpro) at 310 k |
|
67
|
306
|
7mhoA |
Ensemble refinement structure of apo/unliganded sars-cov-2 main protease (mpro) at 298 k |
|
78
|
306
|
7mhmA |
Ensemble refinement structure of apo/unliganded sars-cov-2 main protease (mpro) at 240 k |
|
88
|
306
|
7mngA |
Crystal structure of sars-cov-2 main protease (3clpro/mpro) in complex with covalent inhibitor vby-825 (partial occupancy) |
|
83
|
306
|
7mhjA |
Crystal structure of apo/unliganded sars-cov-2 main protease (mpro) at 298 k and high humidity |
|
89
|
306
|
7mhgA |
Crystal structure of apo/unliganded sars-cov-2 main protease (mpro) at 240 k |
|
70
|
303
|
7lcqA |
N-terminal finger stabilizes feline drug gc376 in coronavirus 3cl protease |
|
82
|
306
|
7mhiA |
Crystal structure of apo/unliganded sars-cov-2 main protease (mpro) at 298 k |
|
70
|
306
|
7mhpA |
Ensemble refinement structure of apo/unliganded sars-cov-2 main protease (mpro) at 298 k at high humidity |
|
82
|
306
|
7mhhA |
Crystal structure of apo/unliganded sars-cov-2 main protease (mpro) at 277 k |
|
87
|
306
|
7mhfA |
Crystal structure of apo/unliganded sars-cov-2 main protease (mpro) at 100 k |
|
76
|
306
|
7mhlA |
Ensemble refinement structure of apo/unliganded sars-cov-2 main protease (mpro) at 100 k |
|
79
|
304
|
7lcpA |
N-terminal finger stabilizes feline drug gc376 in coronavirus 3cl protease |
|
67
|
285
|
7mc6A |
Crystal structure of the sars-cov-2 exon-nsp10 complex containing mg2+ ion |
|
17
|
115
|
7lw3B |
Structure of sars-cov-2 nsp16/nsp10 complex in presence of cap-1 analog (m7gpppamu) and sah |
|
10
|
114
|
7lw4B |
Structure of sars-cov-2 nsp16/nsp10 complex in presence of s-adenosyl-l-homocysteine (sah) |
|
50
|
298
|
7lw3A |
Structure of sars-cov-2 nsp16/nsp10 complex in presence of cap-1 analog (m7gpppamu) and sah |
|
73
|
287
|
7mc5A |
Crystal structure of the sars-cov-2 exon-nsp10 complex |
|
41
|
298
|
7lw4A |
Structure of sars-cov-2 nsp16/nsp10 complex in presence of s-adenosyl-l-homocysteine (sah) |
|
37
|
130
|
7mc5M |
Crystal structure of the sars-cov-2 exon-nsp10 complex |
|
32
|
130
|
7mc6M |
Crystal structure of the sars-cov-2 exon-nsp10 complex containing mg2+ ion |
|
85
|
307
|
7cb7A |
1.7a resolution structure of sars-cov-2 main protease (mpro) in complex with broad-spectrum coronavirus protease inhibitor gc376 |
|
75
|
297
|
7camA |
Sars-cov-2 main protease (mpro) apo structure (space group p212121) |
|
239
|
927
|
7krpA |
Structure of sars-cov-2 backtracked complex complex bound to nsp13 helicase - btc (local refinement) |
|
224
|
927
|
7krnA |
Structure of sars-cov-2 backtracked complex bound to nsp13 helicase - nsp13(1)-btc |
|
222
|
927
|
7kroA |
Structure of sars-cov-2 backtracked complex complex bound to nsp13 helicase - nsp13(2)-btc |
|
91
|
312
|
7d7lA |
Viral protease complex structure |
|
126
|
590
|
7krnE |
Structure of sars-cov-2 backtracked complex bound to nsp13 helicase - nsp13(1)-btc |
|
53
|
186
|
7krnB |
Structure of sars-cov-2 backtracked complex bound to nsp13 helicase - nsp13(1)-btc |
|
141
|
590
|
7kroE |
Structure of sars-cov-2 backtracked complex complex bound to nsp13 helicase - nsp13(2)-btc |
|
21
|
75
|
7krnC |
Structure of sars-cov-2 backtracked complex bound to nsp13 helicase - nsp13(1)-btc |
|
22
|
75
|
7kroC |
Structure of sars-cov-2 backtracked complex complex bound to nsp13 helicase - nsp13(2)-btc |
|
52
|
186
|
7kroB |
Structure of sars-cov-2 backtracked complex complex bound to nsp13 helicase - nsp13(2)-btc |
|
54
|
186
|
7krpB |
Structure of sars-cov-2 backtracked complex complex bound to nsp13 helicase - btc (local refinement) |
|
22
|
75
|
7krpC |
Structure of sars-cov-2 backtracked complex complex bound to nsp13 helicase - btc (local refinement) |
|
97
|
312
|
7d7kA |
Viral protease apo structure |
|
35
|
219
|
7m1vA |
Structure of zika virus ns2b-ns3 protease mutant binding the compound nsc86314 in the super-open conformation |
|
16
|
94
|
7lsgC |
Crystal structure of the human neutralizing antibody fab fragment t025 bound to tbev ediii (siberian subtype) |
|
83
|
305
|
7nf5A |
Crystal structure of mg-132 covalently bound to the main protease (3clpro/mpro) of sars-cov-2 in spacegroup c2. |
|
105
|
605
|
7lhlA |
Cryo-em structure of mycobacterium smegmatis lhr helicase c-terminal domain |
